RecruitingNot applicableNCT04603859
When to INDuce for OverWeight? (WINDOW)
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Aarhus
- Principal Investigator
- Lise Q Krogh, MDAarhus University Hospital
- Intervention
- Elective induction of labor at 39 gestational weeks and 0 to 3 days(procedure)
- Enrollment
- 1900 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2020 – 2026
Study locations (12)
- Aarhus University Hospital, Aarhus, Denmark
- Rigshospitalet Juliane Marie Centre, Copenhagen, Denmark
- Herlev Hospital, Herlev, Denmark
- Gødstrup Regional Hospital, Herning, Denmark
- North Zealand's Hospital, Hillerød, Denmark
- Hvidovre Hospital, Hvidovre, Denmark
- Kolding Hospital, Kolding, Denmark
- Nykøbing Falster Hospital, Nykøbing Falster, Denmark
- Odense University Hospital, Odense, Denmark
- Randers Regional Hospital, Randers, Denmark
- Zealand University Hospital, Roskilde, Denmark
- Viborg Hospital, Viborg, Denmark
Collaborators
Aarhus University Hospital · Randers Regional Hospital · Herning Hospital · Central Jutland Regional Hospital · Nykøbing Falster County Hospital · Odense University Hospital · Rigshospitalet Juliane Marie Centret · Kolding Sygehus · Herlev Hospital · Hvidovre University Hospital · North Zealand's Hospital · Zealand University Hospital - Roskilde
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04603859 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- RECRUITINGPHASE2NCT07328503CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University